0001415889-22-007913.txt : 20220722
0001415889-22-007913.hdr.sgml : 20220722
20220722162729
ACCESSION NUMBER: 0001415889-22-007913
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220712
FILED AS OF DATE: 20220722
DATE AS OF CHANGE: 20220722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Willard Stephen H
CENTRAL INDEX KEY: 0001325232
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38302
FILM NUMBER: 221100196
MAIL ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001719406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822844431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 484-254-6134
MAIL ADDRESS:
STREET 1: 1201 ORANGE STREET
STREET 2: SUITE 600
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp.
DATE OF NAME CHANGE: 20171012
3
1
form3-07222022_010718.xml
X0206
3
2022-07-12
0
0001719406
NRX Pharmaceuticals, Inc.
NRXP
0001325232
Willard Stephen H
C/O NRX PHARMACEUTICALS INC
1201 N. MARKET STREET, SUITE 111
WILMINGTON
DE
19801
true
true
false
false
Chief Executive Officer
Restricted Common Stock, par value $0.001 per share
1000000
D
Grant of an inducement award of 1,000,000 restricted shares of the Company's common stock. The restricted shares will vest in approximately equal installments over three (3) years from July 12, 2022, subject generally to the reporting person's continued service to the Company through the applicable vesting date.
/s/ Stephen Willard
2022-07-22